Real Estate - Services
Compare Stocks
4 / 10Stock Comparison
TCI vs ARL vs NHI vs NXRT
Revenue, margins, valuation, and 5-year total return — side by side.
Real Estate - Development
REIT - Healthcare Facilities
REIT - Residential
TCI vs ARL vs NHI vs NXRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Real Estate - Services | Real Estate - Development | REIT - Healthcare Facilities | REIT - Residential |
| Market Cap | $317M | $223M | $3.64B | $756M |
| Revenue (TTM) | $49M | $50M | $403M | $252M |
| Net Income (TTM) | $9M | $13M | $148M | $-32M |
| Gross Margin | -38.7% | -36.9% | 61.3% | 91.1% |
| Operating Margin | -11.6% | -11.2% | 48.5% | 11.5% |
| Forward P/E | 22.9x | 0.7x | 22.2x | — |
| Total Debt | $211M | $214M | $1.16B | $1.56B |
| Cash & Equiv. | $14M | $14M | $20M | $14M |
TCI vs ARL vs NHI vs NXRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Transcontinental Re… (TCI) | 100 | 181.4 | +81.4% |
| American Realty Inv… (ARL) | 100 | 183.8 | +83.8% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
| NexPoint Residentia… (NXRT) | 100 | 93.2 | -6.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TCI vs ARL vs NHI vs NXRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TCI is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 9.6%, EPS growth 135.3%, 3Y rev CAGR 12.9%
- 324.2% 10Y total return vs ARL's 197.4%
- Lower volatility, beta 0.75, Low D/E 24.3%, current ratio 871.66x
- +18.5% vs NXRT's -15.2%
ARL is the clearest fit if your priority is valuation efficiency.
- PEG 0.06 vs TCI's 1.45
- Lower P/E (0.7x vs 22.2x)
NHI carries the broadest edge in this set and is the clearest fit for growth and quality.
- 12.9% FFO/revenue growth vs NXRT's -3.2%
- 36.8% margin vs NXRT's -12.7%
- 5.4% ROA vs NXRT's -1.7%, ROIC 5.6% vs 1.1%
NXRT is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.62, yield 7.1%
- Beta 0.62, yield 7.1%, current ratio 0.48x
- Beta 0.62 vs ARL's 1.00
- 7.1% yield, 12-year raise streak, vs NHI's 4.8%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.9% FFO/revenue growth vs NXRT's -3.2% | |
| Value | Lower P/E (0.7x vs 22.2x) | |
| Quality / Margins | 36.8% margin vs NXRT's -12.7% | |
| Stability / Safety | Beta 0.62 vs ARL's 1.00 | |
| Dividends | 7.1% yield, 12-year raise streak, vs NHI's 4.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +18.5% vs NXRT's -15.2% | |
| Efficiency (ROA) | 5.4% ROA vs NXRT's -1.7%, ROIC 5.6% vs 1.1% |
TCI vs ARL vs NHI vs NXRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
TCI vs ARL vs NHI vs NXRT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 3 of 6 categories
NXRT leads 1 • TCI leads 0 • ARL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NHI is the larger business by revenue, generating $403M annually — 8.2x TCI's $49M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to NXRT's -12.7%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $50M | $403M | $252M |
| EBITDAEarnings before interest/tax | $5M | $5M | $282M | $125M |
| Net IncomeAfter-tax profit | $9M | $13M | $148M | -$32M |
| Free Cash FlowCash after capex | -$51M | $3M | $226M | $79M |
| Gross MarginGross profit ÷ Revenue | -38.7% | -36.9% | +61.3% | +91.1% |
| Operating MarginEBIT ÷ Revenue | -11.6% | -11.2% | +48.5% | +11.5% |
| Net MarginNet income ÷ Revenue | +18.9% | +25.2% | +36.8% | -12.7% |
| FCF MarginFCF ÷ Revenue | -104.2% | +5.4% | +56.1% | +31.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.8% | +2.8% | +29.7% | +0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -96.2% | -116.7% | +10.8% | 0.0% |
Valuation Metrics
Evenly matched — ARL and NXRT each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 14.2x trailing earnings, ARL trades at a 43% valuation discount to NHI's 24.9x P/E. Adjusting for growth (PEG ratio), ARL offers better value at 1.23x vs TCI's 1.45x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $317M | $223M | $3.6B | $756M |
| Enterprise ValueMkt cap + debt − cash | $513M | $423M | $4.8B | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | 22.91x | 14.23x | 24.85x | -23.65x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 0.66x | 22.17x | — |
| PEG RatioP/E ÷ EPS growth rate | 1.45x | 1.23x | — | — |
| EV / EBITDAEnterprise value multiple | 82.37x | 68.82x | 17.16x | 18.60x |
| Price / SalesMarket cap ÷ Revenue | 6.45x | 4.46x | 9.61x | 3.01x |
| Price / BookPrice ÷ Book value/share | 0.37x | 0.27x | 2.29x | 2.52x |
| Price / FCFMarket cap ÷ FCF | — | — | 16.52x | 9.05x |
Profitability & Efficiency
NHI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-10 for NXRT. TCI carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs ARL's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.1% | +1.6% | +9.8% | -10.1% |
| ROA (TTM)Return on assets | +0.8% | +1.2% | +5.4% | -1.7% |
| ROICReturn on invested capital | -0.5% | -0.5% | +5.6% | +1.1% |
| ROCEReturn on capital employed | -0.6% | -0.6% | +8.0% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.24x | 0.26x | 0.76x | 5.18x |
| Net DebtTotal debt minus cash | $197M | $200M | $1.1B | $1.5B |
| Cash & Equiv.Liquid assets | $14M | $14M | $20M | $14M |
| Total DebtShort + long-term debt | $211M | $214M | $1.2B | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 4.22x | 4.11x | 3.45x | 0.47x |
Total Returns (Dividends Reinvested)
Evenly matched — TCI and NHI each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARL five years ago would be worth $17,692 today (with dividends reinvested), compared to $7,705 for NXRT. Over the past 12 months, TCI leads with a +18.5% total return vs NXRT's -15.2%. The 3-year compound annual growth rate (CAGR) favors NHI at 20.2% vs ARL's -10.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -37.8% | -15.0% | -1.1% | +2.6% |
| 1-Year ReturnPast 12 months | +18.5% | +9.1% | +2.8% | -15.2% |
| 3-Year ReturnCumulative with dividends | +4.7% | -27.7% | +73.5% | -15.5% |
| 5-Year ReturnCumulative with dividends | +72.8% | +76.9% | +31.0% | -23.0% |
| 10-Year ReturnCumulative with dividends | +324.2% | +197.4% | +58.9% | +211.1% |
| CAGR (3Y)Annualised 3-year return | +1.5% | -10.2% | +20.2% | -5.5% |
Risk & Volatility
NHI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than ARL's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHI currently trades 82.5% from its 52-week high vs TCI's 61.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 1.00x | -0.08x | 0.62x |
| 52-Week HighHighest price in past year | $59.65 | $20.00 | $90.94 | $38.30 |
| 52-Week LowLowest price in past year | $29.26 | $11.95 | $68.80 | $23.79 |
| % of 52W HighCurrent price vs 52-week peak | +61.4% | +69.0% | +82.5% | +77.8% |
| RSI (14)Momentum oscillator 0–100 | 46.4 | 40.3 | 28.0 | 71.0 |
| Avg Volume (50D)Average daily shares traded | 7K | 3K | 332K | 216K |
Analyst Outlook
NXRT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NHI as "Hold", NXRT as "Hold". Consensus price targets imply 13.8% upside for NHI (target: $85) vs -9.4% for NXRT (target: $27). For income investors, NXRT offers the higher dividend yield at 7.07% vs NHI's 4.80%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Hold |
| Price TargetConsensus 12-month target | — | — | $85.40 | $27.00 |
| # AnalystsCovering analysts | — | — | 18 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | +4.8% | +7.1% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 1 | 12 |
| Dividend / ShareAnnual DPS | — | — | $3.61 | $2.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +0.5% | 0.0% | +1.0% |
NHI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NXRT leads in 1 (Analyst Outlook). 2 tied.
TCI vs ARL vs NHI vs NXRT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TCI or ARL or NHI or NXRT a better buy right now?
For growth investors, National Health Investors, Inc.
(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). American Realty Investors, Inc. (ARL) offers the better valuation at 14. 2x trailing P/E (0. 7x forward), making it the more compelling value choice. Analysts rate National Health Investors, Inc. (NHI) a "Hold" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TCI or ARL or NHI or NXRT?
On trailing P/E, American Realty Investors, Inc.
(ARL) is the cheapest at 14. 2x versus National Health Investors, Inc. at 24. 9x. On forward P/E, American Realty Investors, Inc. is actually cheaper at 0. 7x.
03Which is the better long-term investment — TCI or ARL or NHI or NXRT?
Over the past 5 years, American Realty Investors, Inc.
(ARL) delivered a total return of +76. 9%, compared to -23. 0% for NexPoint Residential Trust, Inc. (NXRT). Over 10 years, the gap is even starker: TCI returned +324. 2% versus NHI's +58. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TCI or ARL or NHI or NXRT?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus American Realty Investors, Inc. 's 1. 00β — meaning ARL is approximately -1289% more volatile than NHI relative to the S&P 500. On balance sheet safety, Transcontinental Realty Investors, Inc. (TCI) carries a lower debt/equity ratio of 24% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TCI or ARL or NHI or NXRT?
By revenue growth (latest reported year), National Health Investors, Inc.
(NHI) is pulling ahead at 12. 9% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: American Realty Investors, Inc. grew EPS 206. 6% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, TCI leads at 12. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TCI or ARL or NHI or NXRT?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -12. 9% for TCI. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TCI or ARL or NHI or NXRT more undervalued right now?
On forward earnings alone, American Realty Investors, Inc.
(ARL) trades at 0. 7x forward P/E versus 22. 2x for National Health Investors, Inc. — 21. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 8% to $85. 40.
08Which pays a better dividend — TCI or ARL or NHI or NXRT?
In this comparison, NXRT (7.
1% yield), NHI (4. 8% yield) pay a dividend. TCI, ARL do not pay a meaningful dividend and should not be held primarily for income.
09Is TCI or ARL or NHI or NXRT better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 8% yield). Both have compounded well over 10 years (NHI: +58. 9%, ARL: +197. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TCI and ARL and NHI and NXRT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TCI is a small-cap quality compounder stock; ARL is a small-cap deep-value stock; NHI is a small-cap income-oriented stock; NXRT is a small-cap income-oriented stock. NHI, NXRT pay a dividend while TCI, ARL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.